Skip to main content
Clinical Trials/NCT05849844
NCT05849844
Recruiting
Not Applicable

Tympanoseal (Tympanic Membrane Device) Clinical Study

Grace Medical, Inc.2 sites in 1 country45 target enrollmentJanuary 5, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Tympanic Membrane Perforation
Sponsor
Grace Medical, Inc.
Enrollment
45
Locations
2
Primary Endpoint
Number of participants with healed tympanic membrane perforations.
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The purpose of this investigational study is to assess the ability of Tympanoseal (sodium/calcium alginate), an investigational device, to act as a scaffold during healing of the tympanic membrane. Tympanoseal is intended for use following removal or extrusion of indwelling tympanostomy tubes or traumatic injury of the tympanic membrane.

Detailed Description

This study will provide data on the safety and the ability of sodium/calcium alginate gels to act as a scaffold capable of occluding a tympanic membrane perforation over the duration of complete healing. Tympanoseal could be used in cases where cartilage or fat graft tympanoplasty would be indicated.

Registry
clinicaltrials.gov
Start Date
January 5, 2024
End Date
April 20, 2026
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Grace Medical, Inc.
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Male or female patients over 2 years of age at enrollment
  • Documentation of a retained tympanostomy tube or perforation less than 5 mm not on the edge of the tympanic membrane.
  • Written informed consent (and assent when applicable) obtained from subject or subject's legal guardian and ability for subject to comply with the requirements of the study

Exclusion Criteria

  • Active otorrhea or otitis media
  • Otorrhea or otitis media within 4 weeks prior to the operation
  • History of cholesteatoma
  • Perforations on the edge of the tympanic membrane
  • Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data
  • Subject is taking systemic/oral corticosteroids
  • Subject will require the continued use of any type of topical otic medication to the ear(s) with Tympanoseal

Outcomes

Primary Outcomes

Number of participants with healed tympanic membrane perforations.

Time Frame: 12 weeks

The purpose of this investigational study is to assess the safety of Tympanoseal when used during the healing process. Subject will be observed during the study and the the healing process of the tympanic membrane. Information will be gathered via report forms during regular visits of the patient to the investigator.

Secondary Outcomes

  • Number of participants with treatment-related adverse events(12 weeks)

Study Sites (2)

Loading locations...

Similar Trials